A subgroup analysis of the MONICA study: A 12-month, open-label study of add-on montelukast treatment in asthma patients

References

• Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 19:24.
   Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Available at: http://www.ginasthma.com. 2009.
   Google Scholar
• National Institutes of Health. Expert panel report 3: guidelines for the diagnosis and management of asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf.
   Google Scholar
• British Thoracic Society. British guideline on the management of asthma. Available at: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Asthma/Guidelines/asthma_final2008.pdf. 2008 Accessed September 8, 2010.
   Google Scholar
• Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720–1745.
   PubMed Web of Science ®Google Scholar
• Nissim Ben Efraim AH, Levi-Schaffer F. Tissue remodeling and angiogenesis in asthma: the role of the eosinophil. Ther Adv Respir Dis 2008; 2:163–171.
   PubMedGoogle Scholar
• Jarvis B, Markham A. Montelukast: a review of its therapeutic potential in persistent asthma. Drugs 2000; 59:891–928.
   PubMed Web of Science ®Google Scholar
• Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: 1 year, double blind, randomised, comparative trial. BMJ 2003; 327:891.
   PubMed Web of Science ®Google Scholar
• Blake KV. Montelukast: data from clinical trials in the management of asthma. Ann Pharmacother 1999; 33:1299–1314.
   PubMedGoogle Scholar
• Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Busse, S. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997; 52:45–48.
   PubMed Web of Science ®Google Scholar
• Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003; 58:204–210.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Mehta A, Ljungblad L, Mitfessel H. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. Respir Med 2010; 104: 644–651.
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59–65.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14:32–38.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Philip G, Weinstein SF, LaForce CF, Malice MP, Dass SB, Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol 2005; 19:591–598.
   PubMedGoogle Scholar
• van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003; 90:214–222.
   PubMed Web of Science ®Google Scholar
• Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95:551–557.
   PubMed Web of Science ®Google Scholar
• Nayak AS, Philip G, Lu S, Malice MP, Reiss TF. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002; 88:592–600.
   PubMed Web of Science ®Google Scholar
• Weinstein SF, Philip G, Hampel FC, Jr., Malice MP, Swern AS, Dass SB, Onset of efficacy of montelukast in seasonal allergic rhinitis. Allergy Asthma Proc 2005; 26:41–46.
   PubMed Web of Science ®Google Scholar
• Navarro A, Valero A, Julia B, Quirce S. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig Allergol Clin Immunol 2008; 18:233–238.
   PubMed Web of Science ®Google Scholar
• Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000; 106(5 Suppl):S201–S205.
   Google Scholar
• Leonardi S, Marchese G, Marseglia GL, La Rosa M. Montelukast in allergic diseases beyond asthma. Allergy Asthma Proc 2007; 28:287–291.
   PubMedGoogle Scholar
• Casale TB, Dykewicz MS. Clinical implications of the allergic rhinitis-asthma link. Am J Med Sci 2004; 327:127–138.
   PubMed Web of Science ®Google Scholar
• Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57–62.
   PubMed Web of Science ®Google Scholar
• Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006; 61:737–742.
   PubMed Web of Science ®Google Scholar
• Perry TT, Corren J, Philip G, Kim EH, Conover-Walker MK, Malice MP, Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Ann Allergy Asthma Immunol 2004; 93:431–438.
   PubMed Web of Science ®Google Scholar
• Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003; 58:211–216.
   PubMed Web of Science ®Google Scholar
• Taegtmeyer AB, Steurer-Stey C, Spertini F, Bircher A, Helbling A, Miedinger D, Allergic rhinitis in patients with asthma: the Swiss LARA (Link Allergic Rhinitis in Asthma) survey. Curr Med Res Opin 2009; 25:1073–1080.
   PubMed Web of Science ®Google Scholar
• Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008; 63:453–462.
   PubMed Web of Science ®Google Scholar
• Hauser T, Mahr A, Metzler C, Coste J, Sommerstein R, Gross WL, The leucotriene receptor antagonist montelukast and the risk of Churg–Strauss syndrome: a case-crossover study. Thorax. 2008; 63:677–682.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836–844.
   PubMed Web of Science ®Google Scholar